Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)

AP Maggioni, R Latini, PE Carson, SN Singh… - American heart …, 2005 - Elsevier
BACKGROUND: Atrial fibrillation (AF) in heart failure (HF) is generally considered a
negative prognostic factor. Recent studies indicate that the incidence of AF might be …
被引用次数：695 相关文章

[引用][C] Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)

M AP - Am Heart J, 2005 - cir.nii.ac.jp
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : results
from the Valsartan Heart Failure Trial (Val-HeFT) | CiNii Research CiNii 国立情報学研究所 …

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

AP Maggioni, R Latini, PE Carson, SN Singh… - American Heart …, 2005 - europepmc.org
Background Atrial fibrillation (AF) in heart failure (HF) is generally considered a negative
prognostic factor. Recent studies indicate that the incidence of AF might be decreased by …

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

AP Maggioni, R Latini, PE Carson, SN Singh… - American Heart …, 2005 - experts.umn.edu
Background: Atrial fibrillation (AF) in heart failure (HF) is generally considered a negative
prognostic factor. Recent studies indicate that the incidence of AF might be decreased by …

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

AP Maggioni, R Latini, PE Carson, SN Singh… - American Heart …, 2005 - infona.pl
Atrial fibrillation (AF) in heart failure (HF) is generally considered a negative prognostic
factor. Recent studies indicate that the incidence of AF might be decreased by renin …

[引用][C] Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the valsartan heart failure trial (Val-HeFT)

AP MAGGIONI, R LATINI, PE CARSON… - The American heart …, 2005 - pascal-francis.inist.fr
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results
from the valsartan heart failure trial (Val-HeFT) CNRS Inist Pascal-Francis CNRS Pascal …

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)

AP Maggioni, R Latini, PE Carson… - American heart …, 2005 - pubmed.ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) in heart failure (HF) is generally considered a negative
prognostic factor. Recent studies indicate that the incidence of AF might be decreased by …

[引用][C] Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)

AP Maggioni, R Latini, PE Carson - ACC Current Journal Review, 2005 - infona.pl
Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results
From the Valsartan Heart Failure Trial (Val-HeFT) × Close The Infona portal uses cookies, ie …

[引用][C] Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)

M AP - Am Heart J, 2005 - cir.nii.ac.jp
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : results from
the Valsartan Heart Failure Trial (Val-HeFT) | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)

AP Maggioni, R Latini… - ACC Current …, 2005 - No longer published by Elsevier